Search - tctmd.com

Displaying 1 - 20 of 420

Sort: Relevancy | Date

Most PCIs in US Now Done With Radial Access

News Daily News

Most PCIs in US Now Done With Radial Access

Michael O'Riordan

July 10, 2025

TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

Presentation TCT 2024

TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

Presenter: Hamza Naveed

October 28, 2024

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

Presentation TCT 2023

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

Presenter: Mostafa Elbanna

October 26, 2023

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Presentation TCT 2023

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Presenter: Gregg Stone

October 25, 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

April 14, 2023

Top Coronary Artery Disease News of 2022

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presentation AHA 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presenter: Gregg W. Stone

November 07, 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

November 06, 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

The NCDR Has Made a Difference, but Experts See Room for Growth

News Daily News

The NCDR Has Made a Difference, but Experts See Room for Growth

April 28, 2022

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

December 22, 2021

Which PCI Operator Are You? Four Phenotypes Emerge From Big Data

News Daily News

Which PCI Operator Are You? Four Phenotypes Emerge From Big Data

December 06, 2021

Rare Clotting Complication Seen After mRNA Vaccine: Case Report

News Daily News

Rare Clotting Complication Seen After mRNA Vaccine: Case Report

June 28, 2021

Lean Antithrombotic Regimen Recommended After TAVI

News Daily News

Lean Antithrombotic Regimen Recommended After TAVI

April 12, 2021

Fall in Hemoglobin Without Overt Bleeding May Be Prognostic in ACS

News Daily News

Fall in Hemoglobin Without Overt Bleeding May Be Prognostic in ACS

January 26, 2021

CathPCI Model Fails to Capture Excess Bleeding Risk With PCI Plus TAVR

News Daily News

CathPCI Model Fails to Capture Excess Bleeding Risk With PCI Plus TAVR

December 30, 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

October 14, 2020

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction

Presentation TCT 2020

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction

Presenter: Gregg Stone

October 14, 2020

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.